Type 2 Diabetes and Metformin Influence on Fracture Healing in an Experimental Rat Model.
Persons with diabetes have a greater incidence of fractures compared with persons without diabetes. However, very little published information is available concerning the deleterious effect of late-stage diabetes on osseous structure and bone healing. The purpose of the present study was to evaluate the role of diabetes on fracture healing in a rat femur repair model. Thirty-six lean and diabetic Zucker rats were subdivided into 3 groups: (1) 12 lean rats as the control group; (2) 12 diabetic rats without blood glucose control (DM group); and (3) 12 diabetic rats treated with 300 mg/kg metformin to reduce the blood glucose levels (DM + Met group). Radiographs were taken every week to determine the incidence of bone repair and delayed union. All the rats were killed at 6 weeks after surgery. In both the sham-operated and the fractured and repaired femurs, significant decreases in the fracture-load/weight and marginal decreases in the fracture-load between the lean and DM groups were found. Metformin treatment significantly reduced the blood glucose and body weight 12 days postoperatively. Furthermore, a decrease in the fracture-load and fracture-load/weight in the repaired femurs was found in the DM + Met group. Diabetes impairs bone fracture healing. Metformin treatment reduces the blood glucose and body weight but had an adverse effect on fracture repair in diabetic rats. Further investigations are needed to reveal the mechanisms responsible for the effects of type 2 diabetes mellitus on bone and bone quality and the effect of medications such as metformin might have in diabetic bone in the presence of neuropathy and vascular disease.
Associate Professor, Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: Javier.lafontaine@utsouthwestern.edu.
Javier
J
La Fontaine
Assistant Professor, Department of Orthopedics, University of Texas Southwestern Medical Center, Dallas, TX.
Chris
C
Chen
Staff Podiatrist, Orthopaedic Center of the Rockies, Fort Collins, CO.
Nathan
N
Hunt
Consultant Physician/Diabetologist, Tameside General Hospital, Ashton-Under-Lyne, UK.
Edward
E
Jude
Professor, Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX.
Lawrence
L
Lavery
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D017102:Fracture Healing / Q000187:drug effects* / Q000502:physiology; D050723:Fractures, Bone / Q000503:physiopathology* / Q000601:surgery; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008687:Metformin / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011924:Rats, Zucker
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008687:Metformin
diabetes; fracture healing; metformin